Search by Drug Name or NDC

    NDC 00904-6680-67 Major Triple Antibiotic 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g Details

    Major Triple Antibiotic 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g

    Major Triple Antibiotic is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.

    Product Information

    NDC 00904-6680
    Product ID 0904-6680_789e49e8-03f4-42d4-866d-8ef534ba8fb4
    Associated GPIs 90109803104200
    GCN Sequence Number 061415
    GCN Sequence Number Description neomycin/bacitracin/polymyxinB OINT PACK 3.5-400-5K TOPICAL
    HIC3 Q5W
    HIC3 Description TOPICAL ANTIBIOTICS
    GCN 97206
    HICL Sequence Number 033356
    HICL Sequence Number Description NEOMYCIN SULFATE/BACITRACIN ZINC/POLYMYXIN B
    Brand/Generic Brand
    Proprietary Name Major Triple Antibiotic
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate
    Product Type HUMAN OTC DRUG
    Dosage Form OINTMENT
    Route TOPICAL
    Active Ingredient Strength 400; 3.5; 5000
    Active Ingredient Units [USP'U]/g; mg/g; [USP'U]/g
    Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
    Labeler Name Major Pharmaceuticals
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part333B
    Listing Certified Through 2024-12-31

    Package

    NDC 00904-6680-67 (00904668067)

    NDC Package Code 0904-6680-67
    Billing NDC 00904668067
    Package 144 PACKET in 1 CARTON (0904-6680-67) / .9 g in 1 PACKET
    Marketing Start Date 2018-10-04
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL fa696eab-aa51-4f5f-ae34-6e41100c92a1 Details

    Revised: 1/2021